Bowel Preparation QualityAIBPNCT06904209
Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, Without Compromising the Quality of Colonoscopy? An International Multi-centre Randomized Controlled Trial.
A study testing AI in people with Bowel Preparation Quality, run by Chinese University of Hong Kong at 1 site in Hong Kong.
Trial summary
The goal of this study is to assess the clinical and cost-effectiveness of the AI bowel preparation evaluation system in reducing the consumption volume of the standard high-volume PEG regimen before colonoscopy among the older population. Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Bowel Preparation Quality
- What is being tested?
- AI
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,824 participants
- Where
- 1 siteHong Kong
- Study dates
- 1 Jun 2026to 30 Jun 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Who may be able to join
- individual aged 65 years or above
- undergoing colonoscopy for any indication
- requiring a standard high-volume PEG regimen for bowel preparation
- having a smartphone themselves or their caregivers (including ward nurses) having one will be recruited.
Who cannot join
- allergy to PEG,
- suspected or diagnosed gastrointestinal obstruction or perforation,
- suspected or diagnosed ileus
- suspected or diagnosed gastric retention
- suspected or diagnosed toxic colitis, toxic megacolon,
- prior gastrointestinal surgery, and
- unable to provide informed consent.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
The goal of this study is to assess the clinical and cost-effectiveness of the AI bowel preparation evaluation system in reducing the consumption volume of the standard high-volume PEG regimen before colonoscopy among the older population.
Researchers will compare bowel preparation adequacy and other colonoscopy quality matrices, and patient satisfaction between patients using the AI system and those using Standard Practice.
Read the detailed description
Colonoscopy is the gold standard for screening colorectal cancer (CRC), which is the third most common cancer and the second leading cause of cancer-related mortality worldwide. Polypectomy during screening colonoscopy reduces both the long-term incidence and mortality of CRC because the removal of adenomatous polyps, the precursors of CRC, prevents the development of CRC by interrupting the adenoma-carcinoma sequence. As the older population grows, the demand for colonoscopy is increasing rapidly because of indications for treatment, diagnosis and surveillance, as well as the wide global implementation of organized CRC screening program for individuals ≥50 years.
Bowel preparation plays a crucial role in colonoscopy because it directly affects two important quality indicators that contribute to procedural accuracy: cecal intubation rate (CIR) and adenoma detection rate (ADR). Adequate bowel preparation is essential for complete visualization of the colonic mucosa and the detection of colorectal lesions. In contrast, inadequate bowel preparation (IBP) is associated with a lower CIR, longer procedural time, increased risk of complications, higher adenoma miss rate, and increased healthcare costs owing to the need for earlier repeat colonoscopy. These negative consequences place a significant burden on both patients and the healthcare system. IBP is a common issue worldwide, with rates reported to range from 11% to 28% in the general population undergoing colonoscopy and up to 50% in older individuals.
Enhanced bowel preparation instructions are recommended16. Effective strategies include providing additional instructions, visual aids, cartoons, booklets, videos, phone calls, short message services, smartphone applications and mobile messenger.
Over the past decade, there has been an exponential increase in the computational power, reduced data storage costs, improved algorithmic sophistication, and an increased availability of electronic health data. Artificial intelligence (AI) has been widely adopted in various healthcare settings, particularly for colonoscopy17.
A recent meta-analysis reported that brown liquid rectal effluent is one of the most significant risk factors for IBP, increasing the odds by more than 4.5-fold.18. Some newly developed convolutional neural network (CNN)-based AI models, trained using thousands of rectal effluent images, have been validated in randomized controlled trials (RCTs) as effective tools for guiding bowel preparation before colonoscopy19,20. Unlike enhanced instructions that focus on patient education, these AI models allow patients to predict the adequacy of bowel preparation before colonoscopy by analyzing rectal effluent images.
In one study, the AI model demonstrated comparable performance in predicting bowel preparation adequacy to standard practice (SP) of self-evaluation using written instructions with photographic examples (AI: 90.7% vs SP: 91.5%, p=0.976), while patients in AI group achieved a higher mean Boston Bowel Preparation Scale (BBPS) score (7.32±1.4 vs 7.16±1.46, p=0.044)19. In another study, the AI model achieved a higher bowel preparation adequacy rate (88.54% vs 65.59%, p <0.001) and a higher mean BBPS score (6.74±1.25 vs 5.97±1.81, p <0.001) than those in the SP 20. These AI models were developed as mobile apps or websites accessible via smartphones. In HK, the overall smartphone ownership rate has rapidly increased to 93% recently: 73% among individuals aged ≥65 years versus 99% among those aged 45-64 years21. The social media participation rate was 83% across age groups and 78% among those aged ≥45 years22. The AI bowel preparation evaluation system only requires patients to take and upload photographs of their rectal effluent, with the evaluation results provided immediately on the same page, making it simpler to use than social media. This indicates the feasibility of using a smartphone-based AI bowel preparation evaluation system, even in the older population. Caregivers can assist older individuals with low digital literacy with AI evaluations. For those who live alone, have limited mobility, or have advanced medical conditions, the usual practice is to admit them for inpatient colonoscopy. This means that ward nurses can perform AI evaluations.
Although two studies reported the effectiveness of AI in improving the bowel preparation quality, there are several important gaps in the existing research. First, one study had a relatively small sample size of approximately 500 patients20, and both studies were conducted in a single country, limiting the generalizability of their findings. Second, the baseline ADR in the SP group in both studies did not meet the international quality benchmark of 25%23,24. In one study, the baseline bowel preparation adequacy in the SP group was only 65.6%, and the mean BBPS score was 5.97, both of which were below the recommended standard23,25. Third, the same study allowed for a 1 L remedial dose on top of the split 3 L PEG regimen if the rectal effluent was deemed IBP by the patient's or AI evaluation. As a result, more patients in the AI group consumed a total of 4 L PEG compared to those in the SP group20. It is uncertain that if the increase in bowel preparation adequacy rate in the AI group was due to an increased PEG dosage or AI use. Fourth, although both studies reported that AI could enhance bowel preparation adequacy, they failed to demonstrate its efficacy in enhancing adenoma detection during colonoscopy. Finally, most of the patients recruited in these two studies did not have high-risk factors for IBP as they were generally young, healthy, free of advanced medical conditions, and had undergone elective outpatient colonoscopies19,20.
Although there are different bowel preparation regimens, high-volume PEG is the most commonly used, particularly for the older population, because of its high safety and efficacy in achieving adequate bowel preparation quality16,26,27. Older population is also at a higher risk of developing IBP18. One reason for this is that they tend to dislike and poorly tolerate high-volume PEG regimens with unpleasant taste9,27. Thus, there is a clear need to improve the acceptance and tolerability of high-volume PEG regimens in the older population.
To the best of our knowledge, no studies have explored the feasibility and effectiveness of AI bowel preparation evaluation in reducing the consumption of high-volume PEG while maintaining bowel preparation adequacy among older populations who are at higher risk of IBP18 and require standard high-volume PEG for safety reasons16,26,27. Furthermore, the cost-effectiveness of AI bowel preparation evaluation before colonoscopy has not yet been investigated. Therefore, we aimed to conduct a large-scale, international, multi-centre randomized controlled trial (RCT) to assess the clinical and cost-effectiveness of an AI bowel preparation evaluation system in reducing the consumption volume of the standard high-volume PEG regimen among older population, without compromising the bowel preparation adequacy and other colonoscopy quality matrices.
- Conditions
- Bowel Preparation Quality
- Being tested
- AI
- Keywords
- PEG, bowel preparation, colonoscopy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AIDevice
Each photo will be uploaded and analyzed by AI to predict the adequacy of their bowel preparation with immediate results of "pass" or "not pass," indicating if their bowel preparation is adequate or inadequate. If the result is "pass," patients will stop consuming the remaining PEG solution. If the result is "not pass," patients will be advised to gently rub their lower abdomen in a clockwise direction or walk around and continue consuming the remaining PEG until the AI evaluation gives a "pass" result or until the full dose of 3 L PEG have been consumed. If the patient's rectal effluent deems IBP after consumption of the full dose of 3 L of PEG, an additional 1 L or more of PEG will be administered as a remedial dose at the discretion of the physician-in-charge.
| Study group | Role | What they receive |
|---|---|---|
| Standard practice group (SP group) | No intervention | All patients undergoing outpatient colonoscopy will follow the standard bowel preparation regimen, which includes low residue diet three days prior colonoscopy, and high-volume (3 L) PEG (Klean-Prep, Helsinn Birex Pharmaceuticals, Ireland) in split-dose using a tailored measuring cup (Figure 2). Patients will be asked to consume 1 L in the evening before colonoscopy and 2 L in the morning of colonoscopy. To achieve the best bowel-cleansing effect, patients will be instructed to consume 2 L of PEG 3-6 hours before their colonoscopy9,27. Patients will be instructed to consume the purgative at a rate of 250 ml every 15 minutes14 and document the amount consumed. |
| AI bowel preparation (AI group) | Experimental | Patients who were randomized to the AI bowel preparation evaluation group will follow the same standard practice with the addition of an online AI bowel preparation evaluation system via a QR code. They will be instructed to take photos of their rectal effluent each time they use the toilet during the consumption of the split dose of 2 L PEG on the day of colonoscopy. Receives: Device: AI |
What is being measured
The primary outcome is the main question the study is designed to answer.
Volume of PEG consumed
The primary outcome of this study is the volume of PEG consumed before colonoscopy between the AI and SP groups.
Measured: Baseline (before colonoscopy procedure)
Secondary outcomes (8)
BBPS score
BBPS during procedure
Measured: during colonoscopy
Bowel preparation adequacy rate
How adequate the bowel preparation rate
Measured: during colonoscopy
Caecal intubation rate
Rather it was successful or not caecum is reached during colonscopy
Measured: during colonoscopy
Adenoma detection rate
The chance of discovering adenoma
Measured: during colonoscopy
Mean adenoma per colonoscopy
average number of adenoma found
Measured: during colonoscopy
withdrawal time
time it takes to withdraw
Measured: during colonoscopy
bowel preparation tolerability questionnaire
rather person can handle the bowel preparation
Measured: Baseline (before colonoscopy procedure)
satisfaction between AI and SP group questionnaire
rather patient enjoy using AI or not
Measured: Baseline (before colonoscopy procedure)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Apr 2025
- Study start1 Jun 2026 (estimated)
- Primary completion31 Jan 2028 (estimated)
- Study completion30 Jun 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Bowel Preparation QualityStudies of the same condition, open and under way.
- More trials run by Chinese University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 1,824 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Chinese University of Hong Kong
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Thomas Yuen Tung Lam, Chinese University of Hong Kong
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06904209
- Sponsor's protocol ID
- 2024.590
- Acronym
- AIBP
- Status last verified
- Mar 2025
- First submitted
- 25 Mar 2025
- Last updated
- 1 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, Without Compromising the Quality of Colonoscopy? An International Multi-centre Randomized Controlled Trial.
- ClinicalTrials.gov ID
- NCT06904209
- Acronym / sponsor ID
- AIBP / 2024.590
- Conditions
- Bowel Preparation Quality
- Keywords
- PEG, bowel preparation, colonoscopy
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 1,824 participants (estimated)
- Lead sponsor
- Chinese University of Hong KongUniversity, hospital or other
- Study start
- 1 Jun 2026 (estimated)
- Primary completion
- 31 Jan 2028 (estimated)
- Study completion
- 30 Jun 2028 (estimated)
- First posted
- 1 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to assess the clinical and cost-effectiveness of the AI bowel preparation evaluation system in reducing the consumption volume of the standard high-volume PEG regimen before colonoscopy among the older population.
Researchers will compare bowel preparation adequacy and other colonoscopy quality matrices, and patient satisfaction between patients using the AI system and those using Standard Practice.
Detailed description
Colonoscopy is the gold standard for screening colorectal cancer (CRC), which is the third most common cancer and the second leading cause of cancer-related mortality worldwide. Polypectomy during screening colonoscopy reduces both the long-term incidence and mortality of CRC because the removal of adenomatous polyps, the precursors of CRC, prevents the development of CRC by interrupting the adenoma-carcinoma sequence. As the older population grows, the demand for colonoscopy is increasing rapidly because of indications for treatment, diagnosis and surveillance, as well as the wide global implementation of organized CRC screening program for individuals ≥50 years.
Bowel preparation plays a crucial role in colonoscopy because it directly affects two important quality indicators that contribute to procedural accuracy: cecal intubation rate (CIR) and adenoma detection rate (ADR). Adequate bowel preparation is essential for complete visualization of the colonic mucosa and the detection of colorectal lesions. In contrast, inadequate bowel preparation (IBP) is associated with a lower CIR, longer procedural time, increased risk of complications, higher adenoma miss rate, and increased healthcare costs owing to the need for earlier repeat colonoscopy. These negative consequences place a significant burden on both patients and the healthcare system. IBP is a common issue worldwide, with rates reported to range from 11% to 28% in the general population undergoing colonoscopy and up to 50% in older individuals.
Enhanced bowel preparation instructions are recommended16. Effective strategies include providing additional instructions, visual aids, cartoons, booklets, videos, phone calls, short message services, smartphone applications and mobile messenger.
Over the past decade, there has been an exponential increase in the computational power, reduced data storage costs, improved algorithmic sophistication, and an increased availability of electronic health data. Artificial intelligence (AI) has been widely adopted in various healthcare settings, particularly for colonoscopy17.
A recent meta-analysis reported that brown liquid rectal effluent is one of the most significant risk factors for IBP, increasing the odds by more than 4.5-fold.18. Some newly developed convolutional neural network (CNN)-based AI models, trained using thousands of rectal effluent images, have been validated in randomized controlled trials (RCTs) as effective tools for guiding bowel preparation before colonoscopy19,20. Unlike enhanced instructions that focus on patient education, these AI models allow patients to predict the adequacy of bowel preparation before colonoscopy by analyzing rectal effluent images.
In one study, the AI model demonstrated comparable performance in predicting bowel preparation adequacy to standard practice (SP) of self-evaluation using written instructions with photographic examples (AI: 90.7% vs SP: 91.5%, p=0.976), while patients in AI group achieved a higher mean Boston Bowel Preparation Scale (BBPS) score (7.32±1.4 vs 7.16±1.46, p=0.044)19. In another study, the AI model achieved a higher bowel preparation adequacy rate (88.54% vs 65.59%, p <0.001) and a higher mean BBPS score (6.74±1.25 vs 5.97±1.81, p <0.001) than those in the SP 20. These AI models were developed as mobile apps or websites accessible via smartphones. In HK, the overall smartphone ownership rate has rapidly increased to 93% recently: 73% among individuals aged ≥65 years versus 99% among those aged 45-64 years21. The social media participation rate was 83% across age groups and 78% among those aged ≥45 years22. The AI bowel preparation evaluation system only requires patients to take and upload photographs of their rectal effluent, with the evaluation results provided immediately on the same page, making it simpler to use than social media. This indicates the feasibility of using a smartphone-based AI bowel preparation evaluation system, even in the older population. Caregivers can assist older individuals with low digital literacy with AI evaluations. For those who live alone, have limited mobility, or have advanced medical conditions, the usual practice is to admit them for inpatient colonoscopy. This means that ward nurses can perform AI evaluations.
Although two studies reported the effectiveness of AI in improving the bowel preparation quality, there are several important gaps in the existing research. First, one study had a relatively small sample size of approximately 500 patients20, and both studies were conducted in a single country, limiting the generalizability of their findings. Second, the baseline ADR in the SP group in both studies did not meet the international quality benchmark of 25%23,24. In one study, the baseline bowel preparation adequacy in the SP group was only 65.6%, and the mean BBPS score was 5.97, both of which were below the recommended standard23,25. Third, the same study allowed for a 1 L remedial dose on top of the split 3 L PEG regimen if the rectal effluent was deemed IBP by the patient's or AI evaluation. As a result, more patients in the AI group consumed a total of 4 L PEG compared to those in the SP group20. It is uncertain that if the increase in bowel preparation adequacy rate in the AI group was due to an increased PEG dosage or AI use. Fourth, although both studies reported that AI could enhance bowel preparation adequacy, they failed to demonstrate its efficacy in enhancing adenoma detection during colonoscopy. Finally, most of the patients recruited in these two studies did not have high-risk factors for IBP as they were generally young, healthy, free of advanced medical conditions, and had undergone elective outpatient colonoscopies19,20.
Although there are different bowel preparation regimens, high-volume PEG is the most commonly used, particularly for the older population, because of its high safety and efficacy in achieving adequate bowel preparation quality16,26,27. Older population is also at a higher risk of developing IBP18. One reason for this is that they tend to dislike and poorly tolerate high-volume PEG regimens with unpleasant taste9,27. Thus, there is a clear need to improve the acceptance and tolerability of high-volume PEG regimens in the older population.
To the best of our knowledge, no studies have explored the feasibility and effectiveness of AI bowel preparation evaluation in reducing the consumption of high-volume PEG while maintaining bowel preparation adequacy among older populations who are at higher risk of IBP18 and require standard high-volume PEG for safety reasons16,26,27. Furthermore, the cost-effectiveness of AI bowel preparation evaluation before colonoscopy has not yet been investigated. Therefore, we aimed to conduct a large-scale, international, multi-centre randomized controlled trial (RCT) to assess the clinical and cost-effectiveness of an AI bowel preparation evaluation system in reducing the consumption volume of the standard high-volume PEG regimen among older population, without compromising the bowel preparation adequacy and other colonoscopy quality matrices.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Standard practice group (SP group) | No intervention | –All patients undergoing outpatient colonoscopy will follow the standard bowel preparation regimen, which includes low residue diet three days prior colonoscopy, and high-volume (3 L) PEG (Klean-Prep, Helsinn Birex Pharmaceuticals, Ireland) in split-dose using a tailored measuring cup (Figure 2). Patients will be asked to consume 1 L in the evening before colonoscopy and 2 L in the morning of colonoscopy. To achieve the best bowel-cleansing effect, patients will be instructed to consume 2 L of PEG 3-6 hours before their colonoscopy9,27. Patients will be instructed to consume the purgative at a rate of 250 ml every 15 minutes14 and document the amount consumed. |
| AI bowel preparation (AI group) | Experimental | Device: AIPatients who were randomized to the AI bowel preparation evaluation group will follow the same standard practice with the addition of an online AI bowel preparation evaluation system via a QR code. They will be instructed to take photos of their rectal effluent each time they use the toilet during the consumption of the split dose of 2 L PEG on the day of colonoscopy. |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
Key inclusion criteria (4 listed)
- individual aged 65 years or above
- undergoing colonoscopy for any indication
- requiring a standard high-volume PEG regimen for bowel preparation
- having a smartphone themselves or their caregivers (including ward nurses) having one will be recruited.
Key exclusion criteria (7 listed)
- allergy to PEG,
- suspected or diagnosed gastrointestinal obstruction or perforation,
- suspected or diagnosed ileus
- suspected or diagnosed gastric retention
- suspected or diagnosed toxic colitis, toxic megacolon,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AIEach photo will be uploaded and analyzed by AI to predict the adequacy of their bowel preparation with immediate results of "pass" or "not pass," indicating if their bowel preparation is adequate or inadequate. If the result is "pass," patients will stop consuming the remaining PEG solution. If the result is "not pass," patients will be advised to gently rub their lower abdomen in a clockwise direction or walk around and continue consuming the remaining PEG until the AI evaluation gives a "pass" result or until the full dose of 3 L PEG have been consumed. If the patient's rectal effluent deems IBP after consumption of the full dose of 3 L of PEG, an additional 1 L or more of PEG will be administered as a remedial dose at the discretion of the physician-in-charge. | Device | AI bowel preparation (AI group) |
Primary outcome
Volume of PEG consumed
Time frame: Baseline (before colonoscopy procedure)
The primary outcome of this study is the volume of PEG consumed before colonoscopy between the AI and SP groups.
8 secondary outcomes
BBPS score
Time frame: during colonoscopy
Bowel preparation adequacy rate
Time frame: during colonoscopy
Caecal intubation rate
Time frame: during colonoscopy
Adenoma detection rate
Time frame: during colonoscopy
Mean adenoma per colonoscopy
Time frame: during colonoscopy
withdrawal time
Time frame: during colonoscopy
bowel preparation tolerability questionnaire
Time frame: Baseline (before colonoscopy procedure)
satisfaction between AI and SP group questionnaire
Time frame: Baseline (before colonoscopy procedure)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Apr 2025.
- Individual participant dataSharing planned: No
Related trials for Bowel Preparation Quality
Not yet recruiting
Enhanced Ward Rounds for Bowel Preparation Quality in Hospitalized Patients Undergoing Colonoscopy
Colonoscopy, Bowel Preparation
Not yet recruiting
Right Colon Enema to Improve Bowel Preparation Quality During Colonoscopy
Colonic Polyps, Colorectal Neoplasms
Recruiting
A Multi-Center Randomized Controlled Trial on the Impact of Disease Subtype-Based Active Video Education on Bowel Preparation Quality in Patients With Inflammatory Bowel Disease
Inflammatory Bowel Diseases
Not yet recruitingObservational study
Correlation Between Artificial Intelligence-Based Fecal Coverage Area-Quantified Bowel Preparation Quality Score (FQ-BBPS) and Adenoma Detection Rate
Colorectal Adenoma
Active, not recruiting
The Efficacy of AI-Driven Feces Identification for Bowel Preparation Prior to Colonoscopy
AI App Improves Bowel Preparation Quality for Colonoscopy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing AI in people with Bowel Preparation Quality, run by Chinese University of Hong Kong at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 1 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Felix Sia (852-26370428, felixsia@cuhk.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Volume of PEG consumed (time frame: Baseline (before colonoscopy procedure)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2025.